An introduction to AI | 10 June 2019
Mathys & Squire and RSM are pleased to be co-hosting ‘An introduction to AI’ during London Tech Week The event will be held on Monday, June 10th 2019 at 25 Farringdon Street, London, EC4A… read more…
Mathys & Squire Will Be at INTA 2019!
Mathys & Squire will be at this year’s INTA annual meeting in Boston, from 18th – 22nd May Our team will be available to discuss all things trade marks, patents and designs, as well as IP… read more…
When design meets engineering – how to turn great ideas into great products
We talk to Phil Staunton, Managing Director of D2M Innovation Ltd, a design consultancy that helps turn great ideas into brilliant newly manufactured products that sell Manufacturing is the stage at… read more…
Registration: Tips on Securing Your Mark in China
One of the most common issues faced when securing protection in China is the earlier registration of third-party rights, which are then cited against the later application However, there are… read more…
Having your cake and eating it too – innovation in the food and drink industry
The food and drink industry is one of Europe’s largest manufacturing sectors, with, according to FoodDrinkEurope, an annual turnover of €1,109bn However, in order to… read more…
Is the Paradigm for Detecting Infectious Agents About to Change?
Patents provide an alternative and interesting source of information for identifying emerging technology trends One such recently observed trend supports a growing interest in the use of indirect… read more…
The Internet of Things – why it matters to medtech
Nobody can fail to notice the ever-increasing presence of the internet in almost all aspects of daily life, with seemingly everything now having some level of connectivity Medtech is clearly no… read more…
Facebook Sues Over Trade Mark Infringement
Why is Facebook Suing Over Trade Mark Infringement and Cybersquatting Legal action and Facebook is nothing new, but why – and who – is the social media giant suing over trademark infringement and… read more…
CAR-T therapy in the personalised medicine sector
Chimeric antigen receptors (CARs) are artificial proteins that are used to redirect immune system cells to attack targets that are normally invisible to them, such as cancer cells CARs are typically… read more…
